{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-020400","form_type":"8-K/A","ticker":"AIXN","cik":"0000835662","company_name":"AiXin Life International, Inc.","filed_at":"2021-08-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:20.925627+00:00","generated_at":"2026-06-29T09:43:16.929584+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Aixin Life files financial statements for acquired pharmacies; shows 2020 net loss of $185K","bullets":["Acquired entity Chengdu Aixintang Pharmacy (9 pharmacies) had 2020 revenue of $1.26M and net loss of $185K.","Accumulated deficit at Dec 2020 was $1.19M; stockholders' deficit of $987K.","Pro forma financials also include hotel entity from a separate May 2021 acquisition.","Amendment corrects prior 8-K which misstated the acquired entity's name.","Audited and unaudited combined financials now filed for years ended 2020/2019 and Q1 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-020400","json":"https://secwatch.observer/filing/0001493152-21-020400.json","markdown":"https://secwatch.observer/filing/0001493152-21-020400.md","text":"https://secwatch.observer/filing/0001493152-21-020400.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/835662/000149315221020400/0001493152-21-020400-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/835662/000149315221020400/form-8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T09:43:16.929584+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}